News | February 19, 2024
GSK completes acquisition of Aiolos Bio
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
The acquisition of Aiolos includes AIO-001, a potentially best-in-class, long-acting antithymic stromal lymphopoietin (TSLP) monoclonal antibody
The 200 bedded hospital owned & operated by Alexis
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Astellas has acquired abiraterone decanoate being developed by Propella to treat prostate cancer
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene
Advances Amgen's mission to serve patients with rare disease medicines
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
With an annual revenue of about $500 million, Spectrum will become part of the Industrial Solutions line of business within the Electronics & Industrial segment
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Subscribe To Our Newsletter & Stay Updated
